• Founded: 2018
  • Location: Emeryville, CA
  • Employee range: 50 - 200
  • Clinical stage: RD
  • Therapy area: Metabolic disease
  • Drug types: GEN, HEM, CVV, NEU, LNG, ONC
  • Lead product: Undisclosed
  • Product link:
  • Funding: $100M B Jan 2023; $175M B Jan 2022; $65M A Nov 2020
  • Investors: Novo Holdings, Catalio, SymBiosis

job board

Short description:

Gene-Edited Microbial Treatments

Drug notes:

8 additional undisclosed programs RD hemophilia A, cardiovascular diseases, CNS disease, cystic fibrosis, immuno-oncology, undisclosed

Long description:

Founded in 2018, Metagenomi is based in Emeryville, CA. Through metagenomics and artificial intelligence (AI), they are able to uncover novel genetic machinery through the study of natural environments. Metagenomi uses a high-throughput platform to rapidly identify naturally efficient, specific, and targetable proteins that can be used in genome editing. Then, leveraging the power of their metagenomics-powered genome editing toolbox they aim to develop curative medicines. This toolbox includes programmable nucleases, base editors, and RNA- and DNA-mediated insertions or deletions designed to be compatible across both viral and nonviral delivery technologies. Their main focus is treatments for diseases of the liver, muscle, and cardiovascular and central nervous systems.


(Contract) Senior Scientist, Cell Based Assay
Emeryville, CA|3 days ago
Lab Operations Specialist (Contract)
Emeryville, CA|9 days ago
Vice President, Head of Regulatory Affairs
Emeryville, CA|62 days ago
Associate Director, Manufacturing
Emeryville, CA|100+ days ago
Submit your CV for General Consideration
Emeryville, CA|100+ days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy